Literature DB >> 9108119

Mice devoid of gamma-aminobutyrate type A receptor beta3 subunit have epilepsy, cleft palate, and hypersensitive behavior.

G E Homanics1, T M DeLorey, L L Firestone, J J Quinlan, A Handforth, N L Harrison, M D Krasowski, C E Rick, E R Korpi, R Mäkelä, M H Brilliant, N Hagiwara, C Ferguson, K Snyder, R W Olsen.   

Abstract

gamma-Aminobutyric acid type A receptors (GABA(A)-Rs) mediate the bulk of rapid inhibitory synaptic transmission in the central nervous system. The beta3 subunit is an essential component of the GABA(A)-R in many brain regions, especially during development, and is implicated in several pathophysiologic processes. We examined mice harboring a beta3 gene inactivated by gene targeting. GABA(A)-R density is approximately halved in brain of beta3-deficient mice, and GABA(A)-R function is severely impaired. Most beta3-deficient mice die as neonates; some neonatal mortality, but not all, is accompanied by cleft palate. beta3-deficient mice that survive are runted until weaning but achieve normal body size by adulthood, although with reduced life span. These mice are fertile but mothers fail to nurture offspring. Brain morphology is grossly normal, but a number of behaviors are abnormal, consistent with the widespread location of the beta3 subunit. The mice are very hyperactive and hyperresponsive to human contact and other sensory stimuli, and often run continuously in tight circles. When held by the tail, they hold all paws in like a ball, which is frequently a sign of neurological impairment. They have difficulty swimming, walking on grids, and fall off platforms and rotarods, although they do not have a jerky gait. beta3-deficient mice display frequent myoclonus and occasional epileptic seizures, documented by electroencephalographic recording. Hyperactivity, lack of coordination, and seizures are consistent with reduced presynaptic inhibition in spinal cord and impaired inhibition in higher cortical centers and/or pleiotropic developmental defects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108119      PMCID: PMC20582          DOI: 10.1073/pnas.94.8.4143

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Central inhibitory action attributable to presynaptic depolarization produced by muscle afferent volleys.

Authors:  J C ECCLES; R M ECCLES; F MAGNI
Journal:  J Physiol       Date:  1961-11       Impact factor: 5.182

2.  Ontogeny of GABAA receptor subunit mRNAs in rat spinal cord and dorsal root ganglia.

Authors:  W Ma; P A Saunders; R Somogyi; M O Poulter; J L Barker
Journal:  J Comp Neurol       Date:  1993-12-15       Impact factor: 3.215

3.  Chimeric GABAA/glycine receptors: expression and barbiturate pharmacology.

Authors:  V V Koltchine; Q Ye; S E Finn; N L Harrison
Journal:  Neuropharmacology       Date:  1996       Impact factor: 5.250

4.  The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit.

Authors:  P B Wingrove; K A Wafford; C Bain; P J Whiting
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

5.  Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors.

Authors:  H Lüddens; P H Seeburg; E R Korpi
Journal:  Mol Pharmacol       Date:  1994-05       Impact factor: 4.436

6.  A cluster of three GABAA receptor subunit genes is deleted in a neurological mutant of the mouse p locus.

Authors:  Y Nakatsu; R F Tyndale; T M DeLorey; D Durham-Pierre; J M Gardner; H J McDanel; Q Nguyen; J Wagstaff; M Lalande; J M Sikela
Journal:  Nature       Date:  1993-07-29       Impact factor: 49.962

7.  Distribution, prevalence, and drug binding profile of gamma-aminobutyric acid type A receptor subtypes differing in the beta-subunit variant.

Authors:  D Benke; J M Fritschy; A Trzeciak; W Bannwarth; H Mohler
Journal:  J Biol Chem       Date:  1994-10-28       Impact factor: 5.157

8.  Concordance between isolated cleft palate in mice and alterations within a region including the gene encoding the beta 3 subunit of the type A gamma-aminobutyric acid receptor.

Authors:  C T Culiat; L Stubbs; R D Nicholls; C S Montgomery; L B Russell; D K Johnson; E M Rinchik
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

9.  Phenotypic consequences of deletion of the gamma 3, alpha 5, or beta 3 subunit of the type A gamma-aminobutyric acid receptor in mice.

Authors:  C T Culiat; L J Stubbs; C S Montgomery; L B Russell; E M Rinchik
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  Benzodiazepine-induced motor impairment linked to point mutation in cerebellar GABAA receptor.

Authors:  E R Korpi; C Kleingoor; H Kettenmann; P H Seeburg
Journal:  Nature       Date:  1993-01-28       Impact factor: 49.962

View more
  137 in total

Review 1.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

2.  Reciprocal inhibitory connections regulate the spatiotemporal properties of intrathalamic oscillations.

Authors:  V S Sohal; M M Huntsman; J R Huguenard
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

Review 3.  Mechanisms of GABAA receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission.

Authors:  Josef T Kittler; Kristina McAinsh; Stephen J Moss
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

4.  Modulation of absence seizures by the GABA(A) receptor: a critical rolefor metabotropic glutamate receptor 4 (mGluR4).

Authors:  O C Snead; P K Banerjee; M Burnham; D Hampson
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

Review 5.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

6.  Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor.

Authors:  Neil Collinson; Frederick M Kuenzi; Wolfgang Jarolimek; Karen A Maubach; Rosa Cothliff; Cyrille Sur; Alison Smith; Franklin M Otu; Owain Howell; John R Atack; Ruth M McKernan; Guy R Seabrook; Gerry R Dawson; Paul J Whiting; Thomas W Rosahl
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

7.  Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling.

Authors:  Yu Kasugai; Jerome D Swinny; J David B Roberts; Yannis Dalezios; Yugo Fukazawa; Werner Sieghart; Ryuichi Shigemoto; Peter Somogyi
Journal:  Eur J Neurosci       Date:  2010-11-14       Impact factor: 3.386

8.  Disruption of the murine Ap2β1 gene causes nonsyndromic cleft palate.

Authors:  Wei Li; Rosa Puertollano; Juan S Bonifacino; Paul A Overbeek; Eric T Everett
Journal:  Cleft Palate Craniofac J       Date:  2010-03-02

Review 9.  Stem cells and modeling of autism spectrum disorders.

Authors:  Beatriz C G Freitas; Cleber A Trujillo; Cassiano Carromeu; Marianna Yusupova; Roberto H Herai; Alysson R Muotri
Journal:  Exp Neurol       Date:  2012-10-02       Impact factor: 5.330

10.  Clptm1 Limits Forward Trafficking of GABAA Receptors to Scale Inhibitory Synaptic Strength.

Authors:  Yuan Ge; Yunhee Kang; Robert M Cassidy; Kyung-Mee Moon; Renate Lewis; Rachel O L Wong; Leonard J Foster; Ann Marie Craig
Journal:  Neuron       Date:  2018-01-25       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.